Investigation of the immune response in clinically relevant cytomegalovirus and polyomavirus infections in immunocompromised patients (ICB-Imm)

Investigation of the immune response in clinically relevant cytomegalovirus and polyomavirus infections in immunocompromised patients (ICB-Imm) - ICB-Imm

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035872

Enrollment

150

Registered

2025-01-22

Start date

2025-04-09

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B25.9 B34.8

Interventions

Group 1: Living organ donors before kidney transplantation: All living organ donors who have reached the age of 18. Patients in preparation for living kidney transplantation. Recipients of kidney dona

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients must be >= 18 years old and able to give informed consent in order to participate in the study.

Exclusion criteria

Exclusion criteria: - Persons who are in a dependent / employment relationship with the investigators, in particular employees of the clinics and institutes involved in this application - Lack of capacity to consent, e.g. due to language barriers or mental illness - Placement in an institution due to a court or official order

Design outcomes

Primary

Measure	Time frame
CMV infection, BK polyomavirus infection	—

Secondary

Measure	Time frame
kidney function, transplant rejection	—

Countries

Germany

Contacts

Public ContactChristine Kurschat

Klinikum der Universität zu Köln

christine.kurschat@uk-koeln.de0221 478 4480

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026